Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Four years later they launched FreeStyle Libre, a reimagined continuous glucose monitoring (CGM) system in which an even smaller sensor applied to a patient’s arm sends data directly to a ...

The implementation of an inpatient continuous glucose ... and 43% used the FreeStyle Libre® 2. Of the 1506 attempted validations of CGM and fingerstick blood glucose tests, 87.8% met the ...

The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device ...

So, while you should always follow the fundamentals of healthy living – like exercising and eating a balanced diet – ...

Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage of its revenues comes from outside the ...

Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetesWith a single sensor, the ...

This page features the latest news about the Abbott Laboratories BDR share. Abbott FreeStyle Libre Continuous Glucose Monitoring Systems Obtain Significantly Expanded Coverage for Medicare ...